Now that there are several targeted biotech drugs on the market, researchers are starting to test whether two targeted drugs are better than one. 既然市場(chǎng)上有很多靶向生物技術(shù)藥物，那么研究者正開(kāi)始試驗兩個(gè)靶向藥物是否會(huì )比一個(gè)更好些。
The molecular targeted agent, cetuximab and bevacizumab, combined with chemotherapy, would be more promising therapeutic regimens in the treatment of advanced gastric caner. 而將西妥昔單抗和貝伐單抗等分子靶向藥物與化療合用，有望成為更具前景的治療方案。
